August 19, 2026
DEVELOPMENT
FDA
Preliminary
Trump nominates Heidi Overton, White House domestic policy aide, as FDA Commissioner
President Trump nominated Heidi Overton — deputy director of domestic policy at the White House, who has worked closely with HHS Secretary Robert F. Kennedy Jr. and Dr. Oz on health initiatives — to lead the FDA. The nomination follows a stretch of turnover in FDA vaccine leadership that the book documents through Peter Marks's 2025 resignation. Coverage describes her as untested on independent FDA oversight, with observers flagging "competing interests" between administration priorities and the agency's traditional role.
Why it matters
The book's Chapter 8 tracks the FDA's vaccine-division churn — two commissioners and two vaccine-division directors in fourteen months. A nominee who came up through White House domestic policy rather than the agency or independent science continues that pattern rather than breaking it. This is a nomination, not yet a confirmation — the Senate has not voted.
Related: When Science Became Political, Science Under Siege
August 5, 2026
DEVELOPMENT
CDC
Senate confirms Erica Schwartz as CDC Director, ending nearly year-long vacancy
The Senate confirmed Dr. Erica Schwartz, a retired rear admiral in the U.S. Public Health Service Commissioned Corps who helped run COVID-19 testing sites in the first Trump administration, as CDC director by a 51-44 vote. She fills a vacancy that followed her predecessor's removal after a 29-day tenure — the gap the book's Chapter 6 documents as "The Valentine's Day Massacre and After." At her confirmation hearing, Sen. Bill Cassidy pressed her on how she'd resist political pressure from Secretary Kennedy; she gave little detail but told CDC staff she is prepared to "speak truth to power."
Why it matters
This is the book's central open storyline resolving in real time: does the CDC get a director able to act independently, or another one who doesn't survive contact with the agency's political environment? She now has to navigate an active measles outbreak, a foodborne parasite outbreak, and Ebola in Africa — with the vaccine-schedule fight already set by her predecessor's absence.
Related: When Science Became Political, Science Under Siege
August 5, 2026
POLICY CHANGE
HHS
HHS decertifies Kentucky-region organ procurement organization over patient safety failures
HHS decertified Network for Hope, the organ procurement organization serving Kentucky, Indiana, Ohio, and West Virginia, after federal investigators found serious deficiencies in nearly 30% of reviewed cases — including donation procedures continuing on patients showing signs they weren't suitable donors. The case traces to TJ Hoover, a Kentucky man who survived an organ-retrieval attempt in 2021 after opening his eyes and grabbing at doctors' hands during the procedure. The organization is appealing and says it has since implemented a mandatory "pause in procedure" process, now written into Kentucky law.
Why it matters
Not a vaccine story, but the same institution and the same secretary — a data point on how this HHS leadership uses its enforcement authority when the politics aren't polarized. Worth including precisely because it's a case where the agency acted on a documented patient-safety failure rather than a contested scientific claim.
Related: When Science Became Political
July 31, 2026
EVIDENCE UPDATE
CDC
2026 U.S. measles cases surpass 2025's full-year total — highest since 1991
CDC data confirms 2,371 measles cases in 2026 as of July 31 — already above the 2,288 cases the book documents for all of 2025, with five months of the year still to go. South Carolina (670 cases) and Utah (518) are driving the outbreak, followed by Texas. Unlike 2025, no measles deaths have been reported in the U.S. so far in 2026.
Why it matters
The book's core arithmetic — measles needs 95% MMR coverage to stop moving, and coverage has fallen below it — is now producing a worse case count than the year the book documents, even though it hasn't (yet) produced more deaths. NIH Director Bhattacharya, in an August 9 television interview, called the outbreak the worst in 35 years and told viewers directly to vaccinate their kids, a notably unambiguous statement from an administration official.
Related: When Science Became Political
July 15, 2026
EVIDENCE UPDATE
NIH
Survey: 93% of cancer-disparities researchers report disruption from NIH funding cuts
A 122-researcher survey by the American Association for Cancer Research found 93% reported federal policy changes affected their work, 78% were unable to apply for funding they'd otherwise have sought, and 59% had ongoing projects disrupted. The underlying cuts — including 181 National Cancer Institute grants worth over $317 million in the first half of 2025 — predate this survey; what's new is the first systematic measurement of the damage, including stopped clinical trials where enrolled patients lost access to treatment mid-study.
Why it matters
The book's Chapter 7 puts a dollar figure on NIH's 2025 grant terminations — $2.45 billion, 2,291 grants. This survey is the first evidence of what that number actually did to the people running the underlying research, not just the institutions receiving the money. It's exactly the kind of "what do we know now that we didn't before" update the site's evidence-update category exists for.
Related: When Science Became Political